Abstract:Purpose: Radiation-induced intestinal injury (RIII) commonly occur during abdominal-pelvic cancer radiation therapy; however, no effective prophylactic or therapeutic agents are available to manage RIII currently. This study aimed to clarify the potential of probiotic consortium supplementation in alleviating RIII. Methods and materials: Male C57BL/6J mice were orally administered a probiotic mixture comprising Bifidobacterium longum BL21, Lactobacillus paracasei LC86, and Lactobacillus plantarum Lp90 for 30 days before exposure to 13 Gy of whole abdominal irradiation. The survival rates, clinical scores, and histologic changes in the intestines of mice were assessed. The impacts of probiotic consortium treatment on intestinal stem cell proliferation, differentiation, and epithelial barrier function; oxidative stress; and inflammatory cytokines were evaluated. A comprehensive examination of the gut microbiota composition was conducted through 16S rRNA sequencing, while changes in metabolites were identified using liquid chromatography-mass spectrometry. Results: The probiotic consortium alleviated RIII, as reflected by increased survival rates, improved clinical scores, and mitigated mucosal injury. The probiotic consortium treatment exhibited enhanced therapeutic effects at the histologic level compared with individual probiotic strains, although there was no corresponding improvement in survival rates and colon length. Moreover, the probiotic consortium stimulated intestinal stem cell proliferation and differentiation, enhanced the integrity of the intestinal epithelial barrier, and regulated redox imbalance and inflammatory responses in irradiated mice. Notably, the treatment induced a restructuring of the gut microbiota composition, particularly enriching short-chain fatty acid-producing bacteria. Metabolomic analysis revealed distinctive metabolic changes associated with the probiotic consortium, including elevated levels of anti-inflammatory and antiradiation metabolites. Conclusions: The probiotic consortium attenuated RIII by modulating the gut microbiota and metabolites, improving inflammatory symptoms, and regulating oxidative stress. These findings provide new insights into the maintenance of intestinal health with probiotic consortium supplementation and will facilitate the development of probiotic-based therapeutic strategies for RIII in clinical practice.

Radiation-Induced Intestinal Injury: Injury Mechanism and Potential Treatment Strategies.

Radiation-Induced Intestinal Injury: Molecular Mechanisms and Therapeutic Status

Diagnosis and treatment of radiation intestinal injury: current status and perspectives

Potential role of gut microbiota and its metabolites in radiation-induced intestinal damage

Radiation-induced Intestinal Damage: Latest Molecular and Clinical Developments

Radiation-induced gastric injury during radiotherapy: molecular mechanisms and clinical treatment

Microbiota-derived I3A protects the intestine against radiation injury by activating AhR/IL-10/Wnt signaling and enhancing the abundance of probiotics

Radiotherapy-Induced Digestive Injury: Diagnosis, Treatment and Mechanisms

Probiotic Consortia Protect the Intestine Against Radiation Injury by Improving Intestinal Epithelial Homeostasis

Gastrointestinal radiation injury: symptoms, risk factors and mechanisms

Radiation-induced liver injury and hepatocyte senescence

Quercetin Mitigates Radiation-Induced Intestinal Injury and Promotes Intestinal Regeneration Via Nrf2-Mediated Antioxidant Pathway1.

Molecular biological mechanisms of radiotherapy-induced skin injury occurrence and treatment

Ginsenoside Rk1 attenuates radiation-induced intestinal injury through the PI3K/AKT/mTOR pathway

Activation of pyroptosis and ferroptosis is involved in radiation-induced intestinal injury in mice.

Chinese clinical practice guidelines for the prevention and treatment of radiation‐induced rectal injury

[Current Situation and Prospect of Treatment for Radiation-Induced Lung Injury].

Prevention and treatment for radiation-induced skin injury during radiotherapy

The Radio-Protective Effects of (-)- Epigallocatechin-3-gallate (EGCG): Regulating Macrophage Function in Radiation-Induced Intestinal Injury

Gut Bacteria Erysipelatoclostridium and Its Related Metabolite Ptilosteroid A Could Predict Radiation-Induced Intestinal Injury

[Research Progress on the Protective Effect of Intestinal Flora on Radiation-induced Lung Injury in Thoracic Tumors]